Eight genes (NKX6-2, A2BP1, CA10, DBC1, MYO3A, NPTX2, PENK, and SOX11) were significantly highly methylated in the urine sediments of bladder cancer patients as compared to that of control subjects. The gene discussed is PENK; the disease is urinary bladder cancer.